A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was supported by the NIH Big Data 2 Knowledge initiative via the National Institute of Environmental Health Sciences under Award Number K01ES026832, the Stanford Womens Cancers Innovation Award, the Goldman Sachs Foundation Award, the Cancer League Award, the Smart Research Foundation Award, and funds from the Division of Oncology in the Department of Medicine at the Stanford University School of Medicine and the Stanford Cancer Institute. This work was also supported by the Breast Cancer Research Foundation, the Susan and Richard Levy Gift Fund, the Suzanne Pride Bryan Fund for Breast Cancer Research, the Jan Weimer Junior Faculty Chair in Breast Oncology, the Regents of the University of Californias California Breast Cancer Research Program (16OB-0149 and 19IB-0124), the BRCA Foundation, the G. Willard Miller Foundation, the Carole and Alan Kushnir Charitable Fund, PlayForHer, and the Biostatistics Shared Resource of the NIH-funded Stanford Cancer Institute (P30CA124435). The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; the Centers for Disease Control and Preventions National Program of Cancer Registries, under Cooperative Agreement No. 1NU58DP007156; and the National Cancer Institutes SEER Program under Contract No. HHSN261201800032I awarded to the University of California, San Francisco, Contract No. HHSN261201800015I awarded to the University of Southern California, and Contract No. HHSN261201800009I awarded to the Public Health Institute, Cancer Registry of Greater California. This research used data or services provided by STARR, (STAnford medicine Research data Repository) a clinical data warehouse containing live Epic data from Stanford Health Care, the Stanford Childrens Hospital, the University Healthcare Alliance and Packard Childrens Health Alliance clinics and other auxiliary data from Hospital applications such as radiology PACS. STARR platform is developed and operated by Stanford Medicine Research Technology team and is made possible by Stanford School of Medicine Research Office and the Stanford CTSA Award Number UL1TR003142. The ideas and opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All research reported here, including a waiver of individual consent for research use of de-identified data, was approved by the Institutional Review Board (Stanford University and the community-based Sutter Health network)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes